First, to test the hypothesis that local Abeta pathology correlates with specific p-tau species and tau aggregation in AD, we evaluated AD brain insoluble fractions for associations between Abeta and selected p-tau with the highest hyperphosphorylation rates (pT181, pS202, pT217, and pT231). The gene discussed is MAPT; the disease is Alzheimer disease.